Download full report with analyst certification and important disclosures
Mar 30 2022, 16:00 IST/BST
While AerCap’s Q1 2022 results will likely feature significant impairments (up to $2.5bn), it is quietly assured about insurance claims (of up to $3.5bn) and it recently locked in a $3.3bn discount from the GECAS deal, before any synergies. We think the business is well positioned to deliver mid-term shareholder value.
Mar 30 2022, 16:00 IST/BST